GLP-1 Receptor Agonist Semaglutide and SGLT2 Inhibitors after Acute Coronary Syndrome in Patients with Diabetes: Real-World Comparative Outcomes from an Observational Registry

Cardiology (Switzerland) · Published 2026-04-14 · DOI 10.1159/000551964

Authors being retrieved — see the publisher record. https://doi.org/10.1159/000551964

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles